Tag Archives: Watson Health

Boston Tech Watch: IBM, DataXu, Accion, Yottaa, CoachUp & More

[Updated 10/19/18, 5:08 pm. See below.] Rumors of a Boston adtech sale, a top-level departure at IBM’s Watson Health business, more cash to boost A.I. startups, and Boeing backing a space propulsion company dominate the Boston-area’s tech headlines from the week. Read on for more. —Boston firm DataXu is working with a New York investment […]

Vinod Khosla on A.I., Health, and the Future of Working (or Not)

Entrepreneur-turned-venture capitalist Vinod Khosla made big headlines almost six years ago when he wrote a blog post called “Do We Need Doctors or Algorithms?” In it, he said medicine needed to be reinvented and he predicted a new era in which artificial intelligence might replace most of the functions that doctors do now—and do it […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Wisconsin blog main, Wisconsin top stories | Tagged 16 Tech innovation district, A.I., AliveCor, AlphaGo, Computing, deals, Deep Blue, DeepMind, Economy, Elon Musk, Ginger.io, google, health, Health IT, Healthtech, IBM, information technology, Jobs, Khosla Ventures, Life Sciences, Marc Tessier-Lavigne, Medicine, NNT, Number Needed to Treat, people, Robotics, RoboticsAI, Rockefeller University, Stanford University, startups, Tech, Technology, Tesla, VC, Vinod Khosla, Watson Health, xperience, Zebra Medical Vision | Comments Off

Mayo Clinic and Boston Software Maker Add Qrativ to Busy A.I. Sector

This story is part of an ongoing series on A.I. in healthcare. Artificial intelligence systems have become a trendy, but useful means of extracting meaning out of the troves of scientific research and clinical data that institutions produce every year. Startups from San Francisco to Boston have launched with the goal of helping pharmaceutical companies […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, San Francisco blog main | Tagged AI, algorithm, Algorithms, Andreessen Horowitz, Andrew Badley, Artificial Intelligence, artificial intelligence software, Atomwise, Biotech, cancer treatment, clinical research, clinical trials, Cognitive Computing, compound, data, Data Analytics, deals, drug, Drug Development, drug investigation, exome, GE, healthcare, HealthcareAI, IBM, IBM Watson, Life Science, Life Sciences, Machine Learning, Matrix Capital Management, Matrix Partners, Mayo Clinic, Mayo Clinic Ventures, Murali Aravamudan, neural netowrk, Nference, Pharmaceutical, Qrativ, RoboticsAI, Rovi, Scientific Research, Software, software development, startups, TwoXAR, Venture Capital, Veveo, Watson Health | Comments Off

Watson Health and Broad Institute Team Up for $50M Cancer Collaboration

IBM Watson Health has been inking some big partnerships lately. Today the Cambridge, MA-based division of Big Blue said it has formed a five-year, $50 million research collaboration with the Broad Institute of MIT and Harvard. IBM is footing the whole bill and contributing other resources as well. The organizations are teaming up to study […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main | Tagged Broad Institute, cancer, deals, Eric Lander, Harvard University, healthcare, IBM, IT, Life Sciences, MIT, Partnerships, Patients, research, tumors, Watson Health | Comments Off

Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More

It’s a week for the history books. The United Kingdom voted to leave the European Union last night, triggering worldwide financial fears and, perhaps, a breakup of the U.K. itself. Closer to home, Cleveland (pictured) celebrated LeBron James & the Cavaliers’ historic comeback that brought the city its first sports title in over 50 years. […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Detroit blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged Abingworth, Affordable Care Act, Annexon Biosciences, Atlas Venture, Biostage, cancer immunotherapy, Caribou Biosciences, Celgene, CRISPR-Cas9, David Charbonneau, deals, Ebola, Eleven Biotherapeutics, Endocyte, Epizyme, FDA, Gene editing, Harvard University, IBM, IFM Therapeutics, Inovio Pharmaceuticals, IPO, Joseph Kim, Life Sciences, Lycera, medicare, Michael Rape, Mike Sherman, Novartis, Nurix, OrthoPediatrics, Paolo Macchiarini, Paratek Pharmaceuticals, Phil Baran, Rachel Haurwitz, Ron Ellis, Roundups, Savara Pharmaceuticals, Scripps Research Institute, sean parker, Selecta Biosciences, Serendex Pharmaceuticals, startups, tazemetostat, University of Pennsylvania, VC, Watson Health, Zika | Comments Off

See Boston’s Newest Innovators & Influencers this Wed. at INFLUX

It is just two days to Influx, our big multidisciplinary event showcasing set for the afternoon of June 22 at the Science Museum. There is still time to grab your tickets at our Procrastinator’s Special rate, which ends tomorrow. So get them now and save $80. We have an incredible lineup—covering everything from the future […]

Posted in Boston, Boston blog main, National blog main | Tagged Accion Systems, Akamai, Autodesk, Biotech, Brian Gallagher, C4 Therapeutics, Chase Garbarino, cleantech, Colleen Calhoun, Competitiveness, connected devices, Current, Cybersecurity, David Balter, David Chang, David Edwards, deals, Decibel Therapeutics, dell, design, Economics, Economy, EMC, endeca, energy, events, Executiv, GE, GE Ventures, Growth, Harvard Medical School, Harvard University, Health IT, HourlyNerd, IBM, Influx, innovation, Internet of Things, Jody Rose, Ken Anderson, Kevin Starr, Life Sciences, Louis Perna, Marc Cohen, Medicine, MIT, Mobile, NEVCA, Parallel Wireless, Partner, Patrick Petitti, people, Privacy, Rick Rundell, Security, Space, startups, Steve Papa, Tech, Third Rock Ventures, Tom Leighton, VC, VENTUREAPP, Watson Health, Xconomy | Comments Off

Startups: Get Free Tickets to Influx on June 22, Thanks to NEVCA

Our big June conference Influx is just three weeks away. The event was inspired by the influx of newcomers to the Boston innovation community—and we have an amazing array of fresh faces and new companies taking part. But we’d also love to have an influx of startup companies in attendance—and now, courtesy of the New […]

Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged Akamai, Biotech, cleantech, Competitiveness, connected devices, Cybersecurity, Dave Balter, David Edwards, design, Economics, Economy, endeca, energy, events, GE, GE Ventures, Growth, Harvard University, Health IT, IBM, Influx, innovation, Internet of Things, Life Sciences, MIT, Mobile, people, Privacy, Security, Space, startups, Steve Papa, Tech, Tom Leighton, VC, Watson Health, Xconomy | Comments Off

Saver Rate Ends Today for INFLUX—Grab Your Tickets Now

You’re already planning on attending INFLUX, so why wait any longer to buy your tickets? We’re lining up some of the most forward-thinking entrepreneurs, investors, and visionaries who are new to the Boston innovation scene—or blazing fresh trails. Join us for an afternoon of spotlight talks, fireside chats, and panel discussions that will delve into […]

Posted in Boston, Boston blog main, National blog main | Tagged Akamai, Biotech, cleantech, Competitiveness, connected devices, Cybersecurity, David Balter, David Edwards, design, Economics, Economy, endeca, energy, events, GE, GE Ventures, Growth, Harvard University, Health IT, IBM, Influx, innovation, Internet of Things, Life Sciences, MIT, Mobile, people, Privacy, Security, Space, startups, Steve Papa, Tech, Tom Leighton, VC, Watson Health, Xconomy | Comments Off

Agenda Live For Influx—Event Welcomes Boston’s Innovation Newcomers

Every June, Xconomy holds a big Boston event looking at the region’s innovation future. This year is no different, but some big changes are in the air for the Boston tech and life sciences communities—and we retooled our event to explore them. This year’s event is called Influx. It takes place on the afternoon of […]

Join GE, Watson Health, Akamai, and More at INFLUX on June 22

Big companies and innovative startups call Boston home. That’s pretty much always been the case. But now we’re about to see a step change. With GE moving into the Seaport, IBM Watson Health moving into Kendall Square, Dell mega-merging with EMC, and other giants setting up R&D operations (or otherwise expanding their presence), Boston’s profile […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged Akamai, Biotech, Dave Balter, David Chang, David Edwards, events, Fiona Murray, GE, GE Ventures, Harvard University, IBM Watson, Influx, IT, Life Sciences, MIT, Neal Sandy, Paul Tang, people, Software, startups, Steve Papa, Tom Leighton, VC, Venture Capital, Watson Health, Xconomy | Comments Off← Older posts

Tag Archives: Watson Health

Archives

Meta